The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Cloning And Mutagenesis Market During The Forecast Period 2026–2030?
The cloning and mutagenesis market has observed substantial growth over recent years. Its valuation is anticipated to rise from $3.54 billion in 2025 to $4.21 billion in 2026, driven by a compound annual growth rate (CAGR) of 19.1%. Historically, this expansion has been propelled by factors such as the increase in academic research funding, the advancement of recombinant protein research, the broader adoption of genetic engineering tools, the widespread availability of standardized molecular biology kits, and a rise in new biotech company ventures.
The cloning and mutagenesis market is projected for rapid expansion over the coming years, with its size expected to reach $8.5 billion in 2030, driven by a compound annual growth rate (CAGR) of 19.2%. This anticipated growth during the forecast period is fueled by factors such as a heightened demand for gene function investigations, the broadening scope of synthetic biology applications, escalating investments directed towards therapeutic protein development, the wider embrace of automated laboratory platforms, and a sharper emphasis on precision genome editing. Key trends anticipated during this period encompass the increased uptake of high-fidelity cloning kits, a rise in the application of site-directed mutagenesis techniques, a surging demand for CRISPR-based editing instruments, the expansion of automated molecular biology workflows, and an intensified focus on ensuring both reproducibility and accuracy.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10541&type=smp
What Underlying Factors Are Accelerating The Growth Of The Cloning And Mutagenesis Market?
The growing demand for personalized medicine is anticipated to fuel the expansion of the cloning and mutagenesis market in the future. Personalized medicine represents an advanced healthcare strategy that customizes medical treatments and interventions based on the individual traits of each patient. Cloning And Mutagenesis play essential roles in personalized therapies, encompassing disease modeling, drug development, target identification, gene therapy, biomarker discovery, patient-specific cell therapies, pharmacogenomics, and genome editing. For example, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit organization, revealed that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, marking a significant increase from the 6 approvals recorded in 2022. Consequently, the rising need for personalized medicine is acting as a primary driver for the cloning and mutagenesis industry’s growth.
What Market Segments Are Evaluated Within The Cloning And Mutagenesis Market?
The cloning and mutagenesis market covered in this report is segmented –
1) By Product: Cloning Kits, Mutagenesis Kits, Other Products
2) By Technique: Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques
3) By End User: Academic and Research Institutes, Biotechnology Companies, Other End Users
Subsegments:
1) By Cloning Kits: Bacterial Cloning Kits, Yeast Cloning Kits, Viral Cloning Kits, Plasmid Cloning Kits
2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits, Random Mutagenesis Kits, Error-Prone PCR Kits, CRISPR Or Cas9 Mutagenesis Kits
3) By Other Products: Enzymes, Vector Systems, Accessories
What Industry Trends Are Redefining The Cloning And Mutagenesis Market?
Leading companies in the cloning and mutagenesis markets are actively pursuing advanced techniques, such as PCR techniques, to gain a competitive advantage. Polymerase chain reaction (PCR) is a laboratory method in molecular biology for creating numerous copies of a specific DNA segment. As an illustration, in April 2023, Bio-Rad Laboratories, Inc., a US-based biotechnology firm, introduced the ID-Check Speciation Solution, a real-time PCR method designed for meat speciation. This solution allows for the identification of animal species in food, feed, and environmental samples, offering a reliable and quick way to verify raw material origins and enhance production line cleaning processes. It specifically targets mitochondrial DNA from various meat species, including bovine, chicken, duck, goat, horse, sheep, swine, and turkey, exhibiting exceptional sensitivity and the capacity to detect as low as 0.001% of the species DNA. The kit additionally includes a duplex detection system for improved accuracy and ease of use.
Who Are The Top Market Participants Influencing The Cloning And Mutagenesis Market?
Major companies operating in the cloning and mutagenesis market are Thermo Fisher Scientific Inc, Takara Bio Inc, Agilent Technologies Inc, New England Biolabs Inc, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc, GenScript Biotech Corporation, Codex DNA Inc, Integrated DNA Technologies Inc, Bio-Techne Corporation, Sino Biological Inc, OriGene Technologies Inc, Bioneer Corporation, Lucigen Corporation, Inscripta Inc, Creative Biogene, Biomatik Corporation, TransGen Biotech Co Ltd, Jena Bioscience GmbH, EZBioscience, Synbio Technologies LLC
Read the full cloning and mutagenesis market report here:
https://www.thebusinessresearchcompany.com/report/cloning-and-mutagenesis-global-market-report
Which Region Is Projected To Dominate The Cloning And Mutagenesis Market During The Forecast Period?
North America was the largest region in the cloning and mutagenesis market in 2025. Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cloning And Mutagenesis Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10541&type=smp
Browse Through More Reports Similar to the Global Cloning And Mutagenesis Market 2026, By The Business Research Company
Virtual Reality Vr In Medical Simulation Market Report 2026
Wearable Medical Devices Market 2026
https://www.thebusinessresearchcompany.com/report/wearable-medical-devices-market
Virtual Reality Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/virtual-reality-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model